Accelrys Announces Software Licensing Agreement with Gulf Coast Consortia
Accelrys, Inc. (NASDAQ: ACCL) today announced that the Gulf Coast Consortia (GCC) for Quantitative Biomedical Sciences has signed a five-year licensing agreement with Accelrys to provide investigators in the GCC Chemical Genomics (GCC-CG) program with access to scientific software, services and training. The Accelrys software will be used to support multi-disciplinary collaborative research and training programs for the treatment and prevention of diseases, including rare and undertreated cancers.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.